SNTA expects to give further guidance later this year on partnering.
Why dont biotech CEOs just STFU and stop saying stuff like this? All it does is allow for speculation that can drag on for months if not years. So, basically, everyone waits and waits and waits, and then, in December, the big "guidance/update" is ..."we are working toward a partner and will provide updates on this later in 2013."
Everything else sounds good though. The drug could really be a good one.
Market Data 
Markets 
AI
